Brief: Xspray Pharma Partners With Eversana

Xspray Pharma publ AB

23/02/2023 07:18

Feb 23 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * XSPRAY PHARMA PARTNERS WITH EVERSANA FOR THE U.S. LAUNCH
AND
COMMERCIALIZATION OF ITS LEAD PRODUCT, DASYNOC (XS004) FOR THE
TREATMENT OF CHRONIC MYELOID LEUKEMIA (CML) AND ACUTE LYMPHATIC
LEUKEMIA (ALL)

Source text for Eikon:  ID:nMFNvBXqk 
Further company coverage:  XSPRAY.ST 
 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))